Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: SPECT/CT-based 99mTc-ABH2 uptake value in tumor lesions at 1 year. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06194565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06194565.